Bionime Corporation (TPE:4737)

Bionime Revenue

Bionime had revenue of 426.63M TWD in the quarter ending June 30, 2026, a decrease of -9.55%. This brings the company's total for the last twelve months to 1.72B, down -11.64% year-over-year. In the year 2025, Bionime had annual revenue of 1.84B, down -4.92%. That makes Bionime the 27,598th largest company in the world by revenue and 1,294th in Taiwan.

• Revenue (ttm): 1.72B
• Revenue Growth: -11.64%
• P/S Ratio: 2.95
• Revenue / Employee: 3.43M
• Employees: 500
• Market Cap: 5.07B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Other Countries 821.79M 44.7%
• Algeria 530.60M 28.9%
• China 184.76M 10.0%
• United States 134.55M 7.3%
• Republic of Belarus 88.69M 4.8%
• Switzerland 38.11M 2.1%
• United Arab Emirates 24.55M 1.3%
• Egypt 15.55M 0.8%

Fiscal year ended Dec 31, 2025 See the full Bionime breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.84B	-95.16M	-4.92%
Dec 31, 2024	1.93B	178.18M	10.15%
Dec 31, 2023	1.76B	-455.02M	-20.58%
Dec 31, 2022	2.21B	360.67M	19.50%
Dec 31, 2021	1.85B	181.34M	10.87%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error